Decreased Myocardial Chromogranin A Expression and Colocalization With Brain Natriuretic Peptide During Reverse Cardiac Remodeling After Ventricular Unloading

Journal of Heart and Lung Transplantation

Volumn 27, Issue 4, 2008, Pages 442-449

  Wohlschlaeger, Jeremias ^a   von Winterfeld, Moritz ^a   Milting, Hendrik ^b   El Banayosy, Aly ^b   Schmitz, Klaus Jürgen ^a   Takeda, Atsushi ^c   Takeda, Nobuakira ^d   Azhari, Petra ^a   Schmid, Christof ^e   August, Christian ^f   Schmid, Kurt Werner ^a   Baba, Hideo Andreas ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c GUNMA PAZ UNIVERSITY   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CD56 ANTIGEN; CHROMOGRANIN A; NERVE CELL ADHESION MOLECULE;

ADOLESCENT; ADULT; ARTICLE; ASSISTIVE TECHNOLOGY DEVICE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE CELL; HEART SIZE; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN TISSUE; HYPERTROPHY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LEFT VENTRICULAR ASSIST DEVICE; MALE; MORPHOMETRICS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SARCOPLASM; STATISTICAL SIGNIFICANCE; UPREGULATION;

ADOLESCENT; ADULT; ANTIGENS, CD56; CHILD; CHILD, PRESCHOOL; CHROMOGRANIN A; CHRONIC DISEASE; DOWN-REGULATION; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; HYPERTROPHY; MALE; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; NEURAL CELL ADHESION MOLECULES; SARCOPLASMIC RETICULUM; TISSUE DISTRIBUTION; VENTRICULAR REMODELING;

EID: 40949160965     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.01.017     Document Type: Article

References (21)

1. Levine T.B., Francis G.S., Goldsmith S.R., Simon A.B., and Cohn J.N. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49 (1982) 1659-1666
2. Cody R.J., Atlas S.A., Laragh J.H., et al. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 78 (1986) 1362-1374
3. Omland T., Lie R.T., Aakvaag A., Aarsland T., and Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation 89 (1994) 1573-1579
4. Blaschko H., Comline R.S., Schneider F.H., Silver M., and Smith A.D. Secretion of a chromaffin granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature 215 (1967) 58-59
5. Pernow J., Lundberg J.M., Kaijser L., et al. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol 6 (1986) 561-578
6. O'Connor D.T., and Bernstein K.N. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. N Engl J Med 311 (1984) 764-770
7. Ceconi C., Ferrari R., Bachetti T., et al. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J 23 (2002) 967-974
8. Metz-Boutigue M.H., Garcia-Sablone P., Hogue-Angeletti R., and Aunis D. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem 217 (1993) 247-257
9. Curry W.J., Johnston C.F., Hutton J.C., et al. The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera. Histochemistry 96 (1991) 531-538
10. Mahata S.K., O'Connor D.T., Mahata M., et al. Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100 (1997) 1623-1633
11. Aardal S., and Helle K.B. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels. Regul Pept 41 (1992) 9-18
12. Corti A., Mannarino C., Mazza R., Colombo B., Longhi R., and Tota B. Vasostatins exert negative inotropism in the working heart of the frog. Ann N Y Acad Sci 971 (2002) 362-365
13. Imbrogno S., Angelone T., Corti A., Adamo C., Helle K.B., and Tota B. Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action. Gen Comp Endocrinol 139 (2004) 20-28
14. Pieroni M., Corti A., Tota B., et al. Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function. Eur Heart J 28 (2007) 1117-1127
15. Gattenlohner S., Waller C., Ertl G., Bultmann B.D., Muller-Hermelink H.K., and Marx A. NCAM(CD56) and RUNX1(AML1) are up-regulated in human ischemic cardiomyopathy and a rat model of chronic cardiac ischemia. Am J Pathol 163 (2003) 1081-1090
16. Bertrand A.T., Hofstra L., Crijns H.J., Doevendans P.A., and De Windt L.J. Myocyte apoptosis in heart failure. van E, V. Cardiovasc Res 67 (2005) 21-29
17. Kuhn M., Voss M., Mitko D., et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage sheart failure. Cardiovasc Res 64 (2004) 308-314
18. Baba H.A., Grabellus F., August C., et al. Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support. J Heart Lung Transplant 19 (2000) 668-674
19. Zafeiridis A., Jeevanandam V., Houser S.R., and Margulies K.B. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98 (1998) 656-662
20. Milting H., Kassner A., et al. The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types. EL BA. J Heart Lung Transplant 20 (2001) 949-955
21. Bruggink A.H., van Oosterhout M.F., et al. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device. de JN. J Heart Lung Transplant 25 (2006) 174-180